Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes

IF 3.6 3区 医学 Q2 HEMATOLOGY Transplantation and Cellular Therapy Pub Date : 2025-03-01 DOI:10.1016/j.jtct.2024.12.017
Christopher E. Dandoy , Jeffery J. Auletta , Priscila Badia , Alan Bidgoli , Nancy M. Daraiseh , Anna M. DeSalvo , Javier Diaz , Stella M. Davies , Kathleen Demmel , Eleanor Cook , John A. Craddock , John Huber , Megan Sampson , Taylor J. Fitch , Karis French , Sonata Jodele , Samantha M. Jaglowski , Malika A. Kapadia , Nandita Khera , Georgia R. Kent , David Hartley
{"title":"Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes","authors":"Christopher E. Dandoy ,&nbsp;Jeffery J. Auletta ,&nbsp;Priscila Badia ,&nbsp;Alan Bidgoli ,&nbsp;Nancy M. Daraiseh ,&nbsp;Anna M. DeSalvo ,&nbsp;Javier Diaz ,&nbsp;Stella M. Davies ,&nbsp;Kathleen Demmel ,&nbsp;Eleanor Cook ,&nbsp;John A. Craddock ,&nbsp;John Huber ,&nbsp;Megan Sampson ,&nbsp;Taylor J. Fitch ,&nbsp;Karis French ,&nbsp;Sonata Jodele ,&nbsp;Samantha M. Jaglowski ,&nbsp;Malika A. Kapadia ,&nbsp;Nandita Khera ,&nbsp;Georgia R. Kent ,&nbsp;David Hartley","doi":"10.1016/j.jtct.2024.12.017","DOIUrl":null,"url":null,"abstract":"<div><div>The Engraft Learning Health Network (LHN) aims to improve outcomes for patients undergoing transplant and cellular therapy (TCT) through a collaborative, data-driven approach. Engraft brings together diverse stakeholders, including clinicians, patients, caregivers, and institutions, to standardize best practices and accelerate the dissemination of innovations in TCT care. By establishing a multicenter, real-world clinical registry focused on rapid-cycle quality improvement (QI) and implementation research, Engraft seeks to reduce variability in clinical practice to improve TCT outcomes across centers. Initial efforts have centered on developing QI toolkits, sharing de-identified patient data, and building consensus around best practices to reduce non-relapse mortality and improve survivorship. A distinctive feature of Engraft is its commitment to engaging patients and caregivers as equal partners in the network's direction. This manuscript outlines the network's design, early successes, and future goals.</div></div>","PeriodicalId":23283,"journal":{"name":"Transplantation and Cellular Therapy","volume":"31 3","pages":"Pages 123-134"},"PeriodicalIF":3.6000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation and Cellular Therapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666636724008364","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The Engraft Learning Health Network (LHN) aims to improve outcomes for patients undergoing transplant and cellular therapy (TCT) through a collaborative, data-driven approach. Engraft brings together diverse stakeholders, including clinicians, patients, caregivers, and institutions, to standardize best practices and accelerate the dissemination of innovations in TCT care. By establishing a multicenter, real-world clinical registry focused on rapid-cycle quality improvement (QI) and implementation research, Engraft seeks to reduce variability in clinical practice to improve TCT outcomes across centers. Initial efforts have centered on developing QI toolkits, sharing de-identified patient data, and building consensus around best practices to reduce non-relapse mortality and improve survivorship. A distinctive feature of Engraft is its commitment to engaging patients and caregivers as equal partners in the network's direction. This manuscript outlines the network's design, early successes, and future goals.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
移植:促进移植和细胞治疗结果的协作学习健康网络。
移植物学习健康网络(LHN)旨在通过协作、数据驱动的方法改善接受移植和细胞治疗(TCT)患者的预后。Engraft将包括临床医生、患者、护理人员和机构在内的不同利益攸关方聚集在一起,使最佳做法标准化,并加速TCT护理创新的传播。通过建立一个多中心、真实世界的临床注册中心,专注于快速循环质量改进(QI)和实施研究,Engraft寻求减少临床实践中的可变性,以改善各中心的TCT结果。最初的努力集中在开发QI工具包,共享去识别的患者数据,并围绕降低非复发死亡率和提高生存率的最佳实践建立共识。Engraft的一个显著特点是它致力于让患者和护理人员在网络的发展方向上成为平等的合作伙伴。这份手稿概述了网络的设计、早期的成功和未来的目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.00
自引率
15.60%
发文量
1061
审稿时长
51 days
期刊最新文献
Best Practices in Gene Therapy for Sickle Cell Disease and Transfusion-dependent β-Thalassemia. Outcome of Patients with IDH-mutated AML following Allogeneic Stem Cell Transplantation - a Retrospective Analysis on behalf of the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy, DRST. Temporal evolution of functional immune reconstitution after allogeneic HSCT. Clinical Outcome of UCBT for Children with CAEBV: A Retrospective Analysis of a Single Center. Efficacy of Pomalidomide on Motor Performance and Functional Abilities in Patients with Steroid Refractory Chronic Graft versus Host Disease: A Randomized Clinical Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1